This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tohda, G. Articles by Miyamori, I. Search for Related Content PubMed PubMed Citation Articles by Tohda, G. Articles by Miyamori, I.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1998;18:1861-1869.)
© 1998 American Heart Association, Inc.

Original Contributions

Expression of Thrombomodulin in Atherosclerotic Lesions and Mitogenic Activity of Recombinant Thrombomodulin in Vascular Smooth Muscle Cells

Gen Tohda; Koji Oida; Yoshikatsu Okada; Shotaro Kosaka; Eiko Okada; Sadao Takahashi; Hidemi Ishii; Isamu Miyamori

From the Third Department of Internal Medicine, Faculty of Medicine, Fukui Medical University, Fukui, Japan (G.T., K.O., S.K., E.O., S.T., I.M.); the Department of Pathology, Osaka Medical College, Osaka, Japan (Y.O.); and the Department of Public Health, Showa College of Pharmaceutical Sciences, Tokyo, Japan (H.I.).

Correspondence to Koji Oida, MD, Third Department of Internal Medicine, Fukui Medical University, Matsuoka-cho, Fukui 910-11, Japan. E-mail kojio{at}fmsrsa.fukui-med.ac.jp

Abstract—Thrombomodulin (TM), a thrombin receptor protein found on the endothelial cell surface, contains 6 tandem epidermal growth factor (EGF)–like structures. Recombinant human TM peptide containing these 6 EGF-like domains (rTME1–6) exhibits mitogenic activity in Swiss 3T3 cells. We examined the localization of TM in atherosclerotic lesions and the effects of rTME1–6 on the growth of cultured rat vascular smooth muscle cells (SMCs). Immunohistochemical analysis demonstrated that TM antigen was localized on monocytes, macrophages, and vascular SMCs. In cultured vascular SMCs, rTME1–6 accelerated [³H]thymidine uptake into DNA in a dose-dependent manner up to 3.4 times the control level. This mitogenic activity was abolished by addition of polyclonal anti-human TM antibody. The rTME1–6–induced mitogenesis was enhanced by EGF. However, a neutralizing monoclonal antibody against the EGF receptor (monoclonal antibody 225) did not inhibit the mitogenic activity of rTME1–6. Calphostin C, a specific protein kinase C inhibitor, and lavendustin-A, an inhibitor of EGF receptor–specific protein tyrosine kinase, inhibited the mitogenic activities of both rTME1–6 and EGF. Finally, rTME1–6 treatment increased the level of phosphorylated mitogen-activated protein kinase in SMCs. Together, these results suggest that TM expression in atherosclerotic lesions may be associated with promotion of atherosclerosis through its mitogenic activity in vascular SMCs.

Key Words: atherosclerosis • thrombomodulin • smooth muscle cells

This article has been cited by other articles:

				I.-C. Lo, T.-M. Lin, L.-H. Chou, S.-L. Liu, L.-W. Wu, G.-Y. Shi, H.-L. Wu, and M. J. Jiang Ets-1 mediates platelet-derived growth factor-BB-induced thrombomodulin expression in human vascular smooth muscle cells Cardiovasc Res, March 1, 2009; 81(4): 771 - 779. [Abstract] [Full Text] [PDF]

				K. Rabausch, E. Bretschneider, M. Sarbia, J. Meyer-Kirchrath, P. Censarek, R. Pape, J. W. Fischer, K. Schror, and A.-A. Weber Regulation of Thrombomodulin Expression in Human Vascular Smooth Muscle Cells by COX-2-Derived Prostaglandins Circ. Res., January 7, 2005; 96(1): e1 - e6. [Abstract] [Full Text] [PDF]

				M. V. de Wouwer, D. Collen, and E. M. Conway Thrombomodulin-Protein C-EPCR System: Integrated to Regulate Coagulation and Inflammation Arterioscler Thromb Vasc Biol, August 1, 2004; 24(8): 1374 - 1383. [Abstract] [Full Text] [PDF]

				C. E. Hafer-Macko, F. M. Ivey, K. A. Gyure, J. D. Sorkin, and R. F. Macko Thrombomodulin Deficiency in Human Diabetic Nerve Microvasculature Diabetes, June 1, 2002; 51(6): 1957 - 1963. [Abstract] [Full Text] [PDF]

				A. Y. Kim, P. L. Walinsky, F. D. Kolodgie, C. Bian, J. L. Sperry, C. B. Deming, E. A. Peck, J. G. Shake, G. B. Ang, R. H. Sohn, et al. Early Loss of Thrombomodulin Expression Impairs Vein Graft Thromboresistance: Implications for Vein Graft Failure Circ. Res., February 8, 2002; 90(2): 205 - 212. [Abstract] [Full Text] [PDF]

				H. Weiler, V. Lindner, B. Kerlin, B. H. Isermann, S. B. Hendrickson, B. C. Cooley, D. A. Meh, M. W. Mosesson, N. W. Shworak, M. J. Post, et al. Characterization of a Mouse Model for Thrombomodulin Deficiency Arterioscler Thromb Vasc Biol, September 1, 2001; 21(9): 1531 - 1537. [Abstract] [Full Text] [PDF]

				J. E. Freedman Thrombin, Thrombomodulin, and Extracellular Signal-Regulated Kinases Regulating Cellular Proliferation Circ. Res., April 13, 2001; 88(7): 651 - 653. [Full Text] [PDF]

				L. Le Flem, L. Mennen, M.-L. Aubry, M. Aiach, P.-Y. Scarabin, J. Emmerich, and M. Alhenc-Gelas Thrombomodulin Promoter Mutations, Venous Thrombosis, and Varicose Veins Arterioscler Thromb Vasc Biol, March 1, 2001; 21(3): 445 - 451. [Abstract] [Full Text] [PDF]

				A. Y. Kim, P. L. Walinsky, F. D. Kolodgie, C. Bian, J. L. Sperry, C. B. Deming, E. A. Peck, J. G. Shake, G. B. Ang, R. H. Sohn, et al. Early Loss of Thrombomodulin Expression Impairs Vein Graft Thromboresistance: Implications for Vein Graft Failure Circ. Res., February 8, 2002; 90(2): 205 - 212. [Abstract] [Full Text] [PDF]